Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors
Clinical trial NCT02028507 · COMPLETED
Trial details
- NCT number
- NCT02028507
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-13
- Primary completion
- 2019-01-14
- Enrollment
- 693
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.